Metropolitan Life Insurance Company (MetLife)’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $32.4K | Sell |
|
|||||
|
2023
Q4 | $38.6K | Buy |
|
|||||
|
2023
Q3 | $10.2K | Hold |
|
|||||
|
2023
Q2 | $16.8K | Buy |
|
|||||
|
2023
Q1 | $8.35K | Sell |
|
|||||
|
2022
Q4 | $25.1K | Hold |
|
|||||
|
2022
Q3 | $24.6K | Buy |
|
|||||
|
2022
Q2 | $6.86K | Sell |
|
|||||
|
2022
Q1 | $26.1K | Sell |
|
|||||
|
2021
Q4 | $115K | Sell |
|
|||||
|
2021
Q3 | $187K | Hold |
|
|||||
|
2021
Q2 | $274K | Buy |
|
|||||
|
2021
Q1 | $225K | Sell |
|
|||||
|
2020
Q4 | $130K | Hold |
|
|||||
|
2020
Q3 | $67.8K | Hold |
|
|||||
|
2020
Q2 | $120K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $180K | Buy |
|